Skip to content

Different Flow Rates of High-Flow Nasal Cannula on Oxygenation in Patients Undergoing ERCP

Different Flow Rates of High-Flow Nasal Cannula on Oxygenation in Patients Undergoing ERCP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124382
Enrollment
Unknown
Registered
2026-05-11
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subclinical hypoxemia (SpO2 90–94%) and hypoxemia (SpO2 < 90%)

Interventions

Group H2: High-flow HFNC group (FiO2 40%, flow rate 50 L/min):None
Group H1: Low-flow HFNC group (FiO2 40%, flow rate 30 L/min):None
Group C: Conventional low-flow oxygen therapy via nasal cannula:None

Sponsors

Chongqing General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years. 2. American Society of Anesthesiologists (ASA) physical status II–III. 3. 18 kg/m² < Body mass index (BMI) < 35 kg/m². 4. Patients undergoing ERCP under sedation or anesthesia. 5. Procedure duration between 40 and 120 minutes; 6. Complete clinical data available.

Exclusion criteria

Exclusion criteria: 1. Significant upper airway abnormalities or intracranial conditions, including severe nasal obstruction, recent nasal trauma or bleeding, markedly elevated intracranial pressure, or skull base fracture 2. Severe respiratory diseases such as pneumothorax, COPD, severe upper airway stenosis, a known difficult airway, or severe obstructive sleep apnea 3. Severe cardiovascular or cerebrovascular diseases 4. Coagulation disorders, severe hepatic dysfunction, or upper gastrointestinal bleeding with shock 5. Baseline oxygen saturation < 93% 6. Significant missing clinical data 7. Conversion to endotracheal intubation during ERCP;

Design outcomes

Primary

MeasureTime frame
arterial blood gas parameters (PaO2, PaCO2);arterial blood gas parameters;

Secondary

MeasureTime frame
Incidence of subclinical hypoxemia (SpO2 90–94%) and hypoxemia (SpO2 < 90%);patient and operator satisfaction;incidence of airway interventions;

Countries

China

Contacts

Public ContactXin Qiao

Chongqing General Hospital

43099307@qq.com+86 23 63390482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026